Ribavirin small-particle-aerosol treatment of influenza B virus infection.
AUTOR(ES)
Bernstein, D I
RESUMO
In a randomized double-blind trial of aerosolized ribavirin for the treatment of influenza B virus infection, no significant difference was found in the febrile course or symptom score of the ribavirin-treated versus placebo-treated patients. The apparent lack of efficacy in this study as compared with that in previous studies is unexplained.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172268Documentos Relacionados
- Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice.
- Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.
- Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.
- Lack of Interference of Guanosine with Ribavirin Aerosol Treatment of Influenza A Infection in Mice
- Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol.
